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Abstract
Background: The equine faecal microbiota is very complex and remains largely unknown, while interspecies
interactions have an important contribution to animal health. Clostridium difficile has been identified as an
important cause of diarrhoea in horses. This study provides further information on the nature of the bacterial
communities present in horses developing an episode of diarrhoea. The prevalence of C. difficile in hospitalised
horses at the time of admission is also reported.
Results: Bacterial diversity of the gut microbiota in diarrhoea is lower than that in non-diarrhoeic horses in terms of
species richness (p-value <0.002) and in population evenness (p-value: 0.02). Statistical differences for Actinobacillus,
Porphyromonas, RC9 group, Roseburia and Ruminococcaceae were revealed. Fusobacteria was found in horses with
diarrhoea but not in any of the horses with non-diarrheic faeces. In contrast, Akkermansia was among the three
predominant taxa in all of the horses studied. The overall prevalence of C. difficile in the total samples of hospitalised
horses at admission was 3.7 % (5/134), with five different PCR-ribotypes identified, including PCR-ribotype 014. Two
colonised horses displayed a decreased bacterial species richness compared to the remaining subjects studied, which
shared the same Bacteroides genus. However, none of the positive animals had diarrhoea at the moment of sampling.
Conclusions: The abundance of some taxa in the faecal microbiota of diarrhoeic horses can be a result of microbiome
dysbiosis, and therefore a cause of intestinal disease, or some of these taxa may act as equine enteric pathogens.
Clostridium difficile colonisation seems to be transient in all of the horses studied, without overgrowth to trigger
infection. A large proportion of the sequences were unclassified, showing the complexity of horses’ faecal microbiota.
Background
Equine gut microbiota is poorly characterised and stud-
ies are currently underway to increase understanding of
how defined microbial communities are able to interfere
with different bacterial aetiologies of diarrhoea in horses.
Recently, high-throughput amplicon sequencing analysis
has been introduced to investigate the intestinal microbiota
of healthy horses and horses with colitis [1–3]. However,
the equine faecal microbiome is still largely unknown, as
are interspecies interactions and their contribution to ani-
mal health [1, 3].
In horses, diarrhoea and colitis have been associated with
a number of different pathogenic agents, including Clostrid-
ium difficile, Clostridium perfringens, Salmonella spp and
Escherichia coli [4–7]. Clostridium difficile is amongst the
most important agents of diarrhoea and serious colitis in
horses [8]. While both adult horses and foals can suffer C.
difficile enteric disease, it seems that foals are more likely to
be colonised by the bacterium [9]. A diagnosis of C. difficile
infection (CDI) requires clinical suspicion as well as detec-
tion of pre-formed C. difficile toxins TcdA and/or TcdB
(or transcripts) in non-enriched specimens. Other pos-
sible causes of acute colitis must also be ruled out [8].
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However, in most cases of diarrhoea, the aetiology remains
unclear and the prevalence of C. difficile colonisation in
hospitalised horses has rarely been addressed [10, 11].
As in humans, the major risk factors for the develop-
ment of CDI are antibiotic treatment and hospitalisation
[8]. However, some cases of infection have been also re-
ported in horses without previous exposure to these risk
factors, including in foals at 2 to 5 days of age [12]. Fur-
thermore, it has been reported that up to 7 % of horses
carry spores of C. difficile without showing any signs of
diarrhoea [10, 13].
The first objective of this study was to provide fur-
ther information on the nature of the bacterial commu-
nity present in horses developing diarrhoea, including
possible alterations in the microbiota profiles as a result of
antibiotic treatment, through comparison with faeces from
horses without diarrhoea. This study also aimed to examine,
by culture of horse faeces at admission to an Equine Clinic,
the carriage rate of C. difficile. Isolates obtained were char-
acterised in terms of PCR-ribotype, toxigenic activity and
antibiotic resistance. Further metagenetic analyses were per-
formed to compare the faecal microbiota of C. difficile in
colonised and non-colonised horses.
Results
Bacterial community present in horses with and without
diarrhoea
A group of 10 horses with diarrhoea at the moment of
sampling were compared with 10 non-diarrhoeic horses
via metagenetic analysis. All of the animals (n = 20) tested
negative for C. difficile by faeces culture (Table 1). Pyrose-
quencing yielded between 4,000 and 5,000 reads per
sample (Additional file 1). The microbiota composition
for each horse is presented at phylum level (Fig. 1),
Table 1 Detailed information on twenty C. difficile negative horses studied via high-throughput amplicons sequencing analysis with
and without diarrhoea
Clinical history of horses
Date of
sampling
Animal number Age
(years)
Diagnostic Diarrhea Hospital stay
(days)
Antibiotic treatment
(days) 1
NSAIDs
treatment
9/10/13 13 12 Colic + 5 Pen-Gen (1)2 F-M
21/10/13 14 3 Diarrhoea + 3 - -
28/10/13 15 21 Diarrhoea and colic + 2 SXT (2) F-M
5/11/13 17 13 Equine atypical myopathy + 1 - -
18/11/13 23 9 Diarrhoea and colic + 1 - Dipyrone
18/11/13 25 2 Haemorrhagic enterocolitis + 1 - -
Hyperlipemia
22/11/13 26 5 Diarrhoea and weight loss + 1 Xnl (1) F-M
Dipyrone
26/11/13 27 6 Colic + 2 - F-M
26/11/13 28 11 Colic + 4 Pen-Gen-LZ (1)2 F-M
Dipyrone
Firocoxib
19/12/13 29 2 Diarrhoea + 2 - -
8/10/13 11 11 Oesophageal obstruction - 1 Pen-Gen-LZ (1)2 F-M
9/10/13 12 8 Horse fall - 10 Xnl (7)2 Dipyrone
28/10/13 16 21 Wound - 3 SXT (4)2 Dipyrone
7/11/13 18 8 Equine atypical myopathy - 1 - -
8/11/13 19 6 Colic - 1 - -
12/11/13 20 6 Colic - 1 - F-M
13/11/13 21 5 Equine atypical myopathy - 1 - -
18/11/13 22 3 Osteochondritis dissecans screening - 1 - -
18/11/13 24 9 Colic - 2 Pen-Gen (2)2 F-M
19/12/13 30 2 Arthroscopy - 3 - -
NSAIDs nonsteroidal anti-inflamatory dugs
Pen penicillin, Gen gentamicin, Xnl ceftiofur, SXT trimethoprim/sulfamethoxazole, LZ metronidazole
F-M Flunixin meglumine
1Time before antibiotic administration in days 2Antibiotic treatment in progress at the time of sampling
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genus level (Fig. 2) and species level (Additional file 2).
The more abundant bacterial families found for both
groups were Lachnospiraceae (between 7 % and 39 %),
Ruminococcaceae (between 2.7 % and 28.7 %), Verruco-
microbiaceae (between 0 % and 43.1 %), and Prevotel-
laceae (between 0.6 % and 17.5 %). Bacterial diversity
of the gut microbiota in diarrhoea was lower than in non-
diarrhoeic horses (p-value: 0.0105). This effect was ob-
served both in terms of species richness and in the popula-
tion evenness (Fig. 3). Principal coordinate analysis (PCoA)
of the diarrhoeic and non-diarrhoeic horses did show
the sample distribution along the 3 main axes (PC1-PC2-
PC3) (Additional file 3). Analysis of Molecular Variance
(AMOVA) revealed a significant difference between the
variance of both groups taken as a single group and the
variance of each group (sum of squares (ss): 0.53 and 11.66
among and within groups respectively; AMOVA test statis-
tic Fs: 1.57; p-value: 0.006). Unifrac weighted analysis fur-
ther showed that both groups share different population
structure (Wscore: 0.88 and p-value: <0.001). Thus, the
microbiota structure of each group was showed statistically
different from each other. The relative abundance of
each genus in both groups were compared in order to
identify the populations responsible for this difference
(White t-test), leading to statistical differences for Actino-
bacillus, Porphyromonas, RC9 gut group, Roseburia and a
taxonomically undefined population belonging to the
Ruminococcaceae (Ruminococcaceae unclassified) (Fig. 4).
Clostridium difficile prevalence in horses at admission and
strain characterisation
During the three-month study period, the total number of
horses admitted at the clinic for either emergencies or con-
sultation was 302, with 141 hospitalisations. A total of 136
samples were collected from the 134 hospitalised horses
enrolled in the study. Two horses were sampled on two
different times because they suffered a diarrhoeal epi-
sode during hospitalisation. However, these horses did
not test positive for C. difficile on any of the sample days.
The overall prevalence of C. difficile in the faecal micro-
biota of hospitalised horses at admission was 3.7 % (5/134).
All horses testing positive were adult animals aged between
four and 16 years old.
Altogether, 52 of the total of 134 horses studied (38.8 %)
presented gastrointestinal problems at admission, but C.
difficile was isolated from only three of these animals (two
with colic and one with proximal enteritis). In these three
horses a nasogastric tube had been passed before the faecal
Fig. 1 Microbiota faecal composition at phylum level for horses with and without diarrhoea. Bar chart detailing the relative abundance of the 17
core phylotypes common to the two groups of horses (with and without diarrhea)
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collection. However, none of them had previously received
an antibiotic treatment. Nineteen horses (14.2 %) had diar-
rhoea at admission but all tested negative for the bacterium
(Additional File 4).
The remaining 82 horses sampled (61.2 %) were not af-
fected by gastrointestinal disorders. In this group, C. difficile
was detected in two horses. The clinical diagnoses in these
two infected horses were multiple wounds and wound with
tendon injury, respectively. Both had received a similar
antibiotic treatment (gentamicin and penicillin with or
without ceftiofur) and non-steroidal anti-inflammatory
drugs (dypirone). Age (9 years) and the gender (female)
Fig. 2 Microbiota faecal composition at genus level (cumulated mean relative abundance >4 %) for horses with and without diarrhoea. Samples
13, 14, 15, 17, 23, 25, 26, 27, 28 and 29: horses with diarrhoea. Samples 11, 12, 16, 18, 19, 20, 21, 22, 24 and 30: horses without diarrhoea. The
unclassified populations correspond to defined groups of the genus level for which a taxonomical classification assignation to the genus cannot
be attributed. These populations are therefore labelled with the first defined superior hierarchical taxonomic level followed by “_unclassified” to
prevent confusion
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Fig. 4 Bacterial genus whose relative abundance was statistically different between the 2 groups. Result of a White test (p value <0.05). Box plot
showing mean relative sequence abundance of Actinobacillus, Porphyromonas, RC9, Roseburia and Ruminococcaceae_unclassified in horses with and
without diarrhea. The error bar indicates the diversity between samples in terms of proportions of sequences
Fig. 3 Bacterial biodiversity, bacterial richness and bacterial evenness in C. difficile negative horses with and without diarrhoea. Box plot of richness,
evenness and diversity values showed that the microbiota structure of each group (diarrhoeic and non diarrhoeic horses) is statistically different from
each other. Whiskers represent minimum and maximum value. Bottom and top of the box are the first and the third quartile. The median is shown as
a band inside the box
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of the two horses were also the same (Table 2). In terms of
antimicrobial therapy, 54 out of 134 horses studied (40.3 %)
had previously received antimicrobial therapy (prior to the
study period), but most (n = 52) tested negative for C. diffi-
cile. Among them, the most common drug used was ceftio-
fur, which was administered to 16 (11.9 %) horses.
Four of the equine isolates were positive for tcdA, tcdB
and binary toxin CDT genes while only one was non-
toxinogenic. The presence of TcdB was confirmed by
cytotoxicity assay using confluent monolayer MRC-5
cells. None of the isolates presented an 18, 39-base pair
deletion or a deletion at 117 of the tcdC gene. Five differ-
ent PCR-ribotypes were detected. Only one strain had a
ribotype profile associated with the reference Cardiff
collection number (014). The remaining isolates were
identified as UCL237, UCL49, UCL23f and UCL36 (non-
toxigenic PCR-ribotype). PCR-ribotypes UCL49, 014 and
UCL23f were isolated from three animals with gastrointes-
tinal problems while PCR-ribotypes UCL237 and UCL36
were recovered from the two horses with wounds (Table 2).
Only the non-toxigenic strain PCR-ribotype UCL36
showed resistance to metronidazole (minimum inhibi-
tory concentration (MIC) = 40 μg/ml, average of two
essays) and erythromycin. For clindamycin, only one
isolate (PCR-ribotype 014) was susceptible, while all
others were fully resistant. Intermediate resistance for
penicillin was observed in all of the isolates tested. The iso-
late PCR-ribotype UCL237 also exhibited intermediate re-
sistance to tetracycline, while all the rest were susceptible.
There was no vancomycin, moxifloxacin or rifampicin
resistance detected, but all the strains were resistant to
ceftiofur (Table 2).
Microbiota composition for C. difficile positive and
negative horses
Stool samples from all horses testing positive for C. diffi-
cile (n = 5) were studied in order to obtain further infor-
mation about the microbiota composition of the colonised
subjects. As during the entire study period (3 months) only
five animals were positive for the bacterium, we could only
use five C. difficile-negative horses as control group, but
with similar clinical history (Additional file 5). In both C.
difficile colonised and non-colonised horses, the dominant
taxa were Lachnospiraceae (ranging from 3.2 to 20.8 %),
Bacteroidales (ranging from 5 to 29.0 %) and Ruminococca-
ceae (ranging from 7 to 17.9 %). In the group of C. difficile
positive horses, only one animal (10) presented a predom-
inance of Bacteroides (36.8 %) and Akkermansia (19.5 %).
The same Bacteroides genus was found in another C. diffi-
cile positive sample (01) at a level of 7.2 % (Fig. 1). Only 45
distinct OTUs (with a mean abundance greater than 4 %)
were identified, representing 25-40 % of the relative abun-
dance of the microbial taxa in the faecal samples (Fig. 5
and Additional file 6).
However, bacterial biodiversity, bacterial richness and
bacterial evenness were not statistically different be-
tween C. difficile colonised and non-colonised horses
(p-value > 0.05). Ordination analysis with PCoA sup-
ported the grouping of most of the individuals into
one group (Additional file 7), which confirmed by non
significant results from AMOVA (sum of squares (ss)
0.41 and 3.18 among and within groups respectively; test
statistic for AMOVA (Fs) 1.03; p-value: 0.389) and Unifrac
analysis of sample clustering (Wscore: 0.97 and p-value:
0.92). Indeed, White test abundance population compari-
son between groups performed at the different taxonomical
levels identified two taxa (RF16 group and Clostridiales) for
which the relative abundance was statistically different
(Additional file 8).
Microbiota composition relation with gastro-intestinal
disorder diagnostics
We grouped the microbiota profiling data from the 20 sam-
ples from diarrhoeic and non diarrhoeic samples with the
10 C. difficile positive and negative samples together
and assigned them to diagnosis categories: Colic (n = 12),
Enteritis (n = 1), Enterocolitis (n = 1), diarrhoea (n = 3) and
others (13). We used this clustering in order to identify
genus whose abundance could be related to one particular
category. Statistical abundance comparison with ANOVA2
between colic, diarrhoea and other categories highlight a
higher abundance of Escherichia and Streptococcus genera
in colic group compared to the others and higher abun-
dance of Akkermansia, Fusobacterium, Porphyromonas
and Xylanibacter genera in the Diarrhoea group (Additional
file 9). Enteritis and Enterocolitis group, having only one
sample could not be included in statistical abundance
comparison but each sample was dominated by 2
defined genus: Bacteroides and Parabacteroides in the
Enteritis sample and Porphyromonas and Fusobacter-
ium Enterocolitis sample (Additional file 10).
Discussion
High-throughput amplicon sequencing analysis is one of
the methods of choice in the study of complex gut micro-
biota ecosystems [14]. However, most of the studies re-
ported bacteria populations at the phylum and class
level while the genus and species level were explored only
in a few recent studies [15, 16]. Higher taxonomic resolu-
tions (genus or species level) may reveal more differences
in population structure than phylum or class level [17]
and provide the degree of precision necessary for clin-
ical diagnosis [18]. As previously demonstrated, select-
ing the accurate region of 16S ribosomal DNA (rDNA)
gene to sequence is essential in determining the utility
of microbial genomics for species-level assignments [19].
In the present study we report genus and species labelling
based on V1-V3 region.
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Table 2 Detailed information on C. difficile positive horses, including molecular characterization and antibiotic resistance of the isolates
C. difficile positive horses Isolates characterisation
Date of
sampling
Animal
identification
Age
(years)
Diagnostic Diarrhoea Hospital
stay (days)
Antibiotic
treatment
(days)e
AINS treatment PCR-ribotype CE tcdA
tcdB
cdtA
cdtB
tcdCa gyrAb MUT PEN CC TE VA MXF
RA
LZE XNL
15/10/2013 01 9 Wound and
tendon injury
- 1 Pen-Gen-Xnl
(1)f
Dipyrone UCL237 + + - - I R I S S R
05/11/2013 03 16 Colicc - 1 - Flunixin
meglumine
UCL49 + + - - I R S S S R
12/11/2013 04 4 Colicd - 2 - - 014 + + - - I S S S S R
03/12/2013 09 9 Multiple wounds - 4 Pen-Gen (5)f Dipyrone UCL36 - - - - I R S S R R
09/12/2013 10 4 Proximal enteritis - 4 - Firocoxib Meloxidyl
Dipyrone
UCL23f + + - - I R S S S R
MUT mutation
CE cytotoxicity assay using confluent monolayer MRC-5 cells
Gen gentamicin, Pen penicillin, CC clindamycin, TE tetracycline, VA vancomycin, MXF moxifloxacin, RA rifampicin, LZ metronidazole, E erythromycin, XNL ceftiofur
Iintermediate antimicrobial resistance
aPresence of deletions in the regulator gene tcdC (118 bp-39 bp-17 bp)
bPresence of mutation in the gyrA gene associated with moxifloxacin resistance
cColic secondary to a gaseous distension of the caecum and a retraction of the colon
dColic secondary to a pelvic flexure impaction (suspicion of a digestive tract verminosis causing weight loss)
eTime before antibiotic administration in days fAntibiotic treatment in progress at the time of sampling
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To determine whether the presence of diarrhoea was re-
lated to changes in the composition of the faecal microbiota
of horses, a strict screening process was carried out among
all the samples obtained over three months, in order that
the two groups (with and without diarrhoea) were as simi-
lar as possible and therefore comparable. As observed in a
previous study investigating the microbiota in the equine
large intestine via 16S ribosomal DNA sequencing [1],
a great part of the sequences (60 %) were not identical
(less than 1 % mismatch) to sequence entries present in
SILVA database (v1.15). Even among the sequences identi-
cal to known entries, the species name was seldom taxo-
nomically defined. These findings underline the lack of
knowledge regarding a good part of the horse gut micro-
biota stressing the need for further research on funda-
mental microbiology either on taxonomic as well on the
functional level.
Interestingly, Akkermansia was found in 90 % of horses
studied, with a relative abundance ranging between 0.03 %
and 43.1 %. This bacterium is an appealing candidate to
become a human probiotic, selected based on established
mechanisms of preventative treatment of obesity and dia-
betes [20–22]. Only one previous study [23] describes the
genus Akkermansia in the equine intestinal microbiota In
this study we reported the presence of Akkermansia muci-
niphila and Akkermansia EU779370 in the faecal micro-
biota of horses with and without diarrhoea. Akkermansia
EU779370 population identified in this study is 100 %
identical to the Akkermansia EU779370 GenBank entry
(for the sequenced V1-V3 section). It represents a po-
tential new Akkermansia species as it shares only 90 %
of nucleotide identity with Akkermansia muciniphila. The
relevance of this finding deserves further investigation.
Overall, the composition of the microbiota of all horses
studied was dominated by the same taxa as previously de-
scribed [4]. However, the differences observed in the cumu-
lative mean relative abundance among individuals in these
dominant bacterial groups may be linked to recent dietary
history [17] or to antimicrobial therapy [23]. Diarrhoea has
been associated with changes in the faecal microbiota com-
position of humans but alterations in the equine gut micro-
biota has been rarely addressed [24]. In the present study,
Fig. 5 Microbiota faecal composition at genus level (cumulated mean relative abundance >4 %) of C. difficile culture-positive and -negative horses.
Samples HF_01, 03, 04, 09 and 10: C. difficile positive horses detected by faeces culture. Samples HF_02, 05, 06, 07 and 08: C. difficile negative horses
detected by faeces culture
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Actinobacillus (0.3 % mean abundance in diarrhoeic group
versus 0.004 in non-diarrhoeic group) and Porphyromonas
taxa (5.6 % mean abundance in diarrheic group versus
0.002 in non-diarrhoeic group) were detected more abun-
dantly in horses with diarrhoea. These results contrast with
a previous study of commensal bacteria in acute diarrhoea
in children, where Porphyromonas species were in the
lowest proportions during acute diarrhoea compared
with levels during periods of normal gastrointestinal health
[25]. Fusobacteria were found in horses with diarrhoea but
not in any of the horses with normal faeces. In a previous
study, Fusobacterium spp. was also found in higher per-
centages in horses with colitis, which could be a conse-
quence of overgrowth due to bacterial dysbiosis or an
aetiological agent of disease [4]. In human beings, Fuso-
bacteria have been associated with colorectal carcinomas
and adenomas [26]. However, there are no previous studies
describing this bacterium as an equine enteropathogen [4].
After clustering of the different feces samples into more
defined diagnosis categories, genus Escherichia and Strepto-
coccus were more abundant in horses with diarrhoea with-
out any other symptoms. A more refined analysis revealed
that the species involved were Escherichia coli and Strepto-
coccus equinus. If the first is long known to be associated
with diarrhoea, the second is the most common Streptococ-
cus found in horse feces. In the colic group, Fusobacterium
and Porphyromonas genera were found in higher amount
compared to other groups but were composed of yet un-
known species. As mentioned above, little is known regar-
ding the involvement of these bacteria in gastro-intestinal
disorders. Finally, two horses suffered from enteritis and
enterocolitis and their 16S profiling revealed a domination
(above 30 % of the sample sequences) of genus Bacteroides
in the enteritis case and genus Porphyromonas in the
enterocolitis case. The Bacteroides population was mainly
represented by Bacteroides heparinolyticus. This species,
originally characterised as an agent of periodontitis in hu-
man [27], is phylogenetically related to Bacteroides fragilis
which is well-known enterotoxinogenic bacteria involved
in human infections [28]. However, there is still no evi-
dence of B. heparinolyticus involvement in gut disorder
in horse or in human and it is thus unclear whether its
abundance is related to the symptomatology.
We are aware that the limited size of the analysed cohort
reduces the strength and the scope of our results. Lar-
ger cohort studies will be needed to improve our know-
ledge on diarrhoea impact on horse microbiota.
In the present study, the carriage of C. difficile at the
time of admission was examined. The overall prevalence
found was 3.7 % (5/134). None of the positive animals had
diarrhoea at the moment of sampling which may suggest
that C. difficile colonisation in these horses was transient
in most cases. In the literature, there is only one previous
study that investigated the presence of C. difficile in horses
at admission to a veterinary teaching hospital [11]. Our re-
sults correlate with the findings of this study, which re-
ported a prevalence of 4.8 % (4/82). In another previous
study conducted at the same Belgian Equine Clinic, we
observed a C. difficile colonisation rate of 13.7 % (10/73).
However, in that study, animals were not only sampled
at the time of admission but also tracked during their
hospitalisation, which could explain the higher preva-
lence found [10].
From the five C. difficile positive horses found, three
of them presented gastrointestinal problems (colic and
proximal enteritis) with a nasogastric tube passed before
sampling. Nasogastric tube placement has been previously
identified as a risk factor for C. difficile infection [11]. Two
other horses without enteric perturbations were also colo-
nised by C. difficile. Both had suffered wounds and were
treated with antibiotics. Previous studies reported intes-
tinal flora perturbations and antibiotic exposure as the
most significant risk factors for C. difficile proliferation
in horses [5].
There were five different PCR-ribotypes detected among
the five C. difficile positive animals, which suggests that a
wide variety of C. difficile strains circulate in horses, as
previously reported [11, 29], including PCR-ribotype 014.
All the isolates were resistant to ceftiofur and four out of
five were also resistant to clindamycin, which agrees with
the findings of previous studies [10, 30]. Only one isolate
was resistant to metronidazole and erythromycin. Sur-
prisingly, this strain (PCR-ribotype UCL36) was the only
non-toxigenic isolate. A high degree of resistance to anti-
microbials (including erythromycin and clindamycin) in
non-toxigenic strains has been reported previously [30] but
the role in disease development or prevention is still
unknown [31].
We were unable to identify C. difficile by pyrosequenc-
ing analysis in the stool samples with positive cultures.
In humans, it is considered that feces harbour up to 1012
bacteria per gram [32]. Thus, our sampling of thousands
of sequences limits our detection ability to populations
above 109 bacteria per gram. The horses testing positive
by culture did not have any clinical signs of C. difficile
disease and the isolate was obtained only after three days
of enrichment. While the results of high-throughput ampli-
con sequencing analysis are limited by the small number of
animals positive for C. difficile, and by the fact that none of
the animals suffered CDI, the findings for each colo-
nised horse should not be dismissed as they provide a
first insight, albeit limited, about the impact of C. diffi-
cile colonisation in the horses’ gut microbiota, which
merits further investigation.
Conclusions
Metagenomic analysis is a promising tool to identify correla-
tions between changes in the gut microbiota and intestinal
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diseases. The abundance of Actinobacillus, Porphyromonas
and Fusobacteria in the faecal microbiota of diarrhoeic
horses deserves special attention, as it can be a result of
microbiome dysbiosis, and therefore a cause of intes-
tinal disease, or in the case of Fusobacteria, may act as
equine enteric pathogen. Furthermore, the high propor-
tion of Akkermansia in all of the horses studied and its
role in the intestine merits further investigation. Clos-
tridium difficile colonisation seems to be transient in
all of the horses studied without overgrowth to trigger
infection. For a great variety of bacterial species the cur-
rently available systems are not able to confidently assign
taxonomy, which shows how complex and still unknown
the equine microbiome is.
Methods
Inclusion criteria and sampling
Samples were collected over a three month period (October
to December 2013) at the Equine Clinic, Department of
Companion Animals and Equids, Faculty of Veterinary
Medicine, University of Liege.
All hospitalised horses during this period with a clinic
stay of at least one day were eligible. Subjects were all se-
lected without regard to their diagnosis or the possible dur-
ation of hospitalisation. The exclusion criteria were horses
exhibiting dysphoric mood, intolerable stress, or any other
disease for which sampling by rectal manipulations was
not recommended. Samples were collected between day
one and day two following admission. In addition, all horses
developing an episode of diarrhoea during their hospital
stay were sampled for a second time. Horses were docu-
mented for data relating to clinical history, diagnostic find-
ings and treatment received, including the prescription of
antimicrobial agents. Faecal sampling was performed dir-
ectly via rectal. Samples obtained were scored as nor-
mal faeces, diarrhoea or bloody diarrhoea faeces. All
samples were processed on the same day immediately
after transport (at room temperature) to the laboratory
(approximately 15 min after sampling). In cases of emer-
gency admission (i.e., during the night or on a non-working
day), two samples per horse were collected. The first sam-
ple was collected in an individual identified sterile 50 ml
tube for further culture to detect C. difficile; the second
was collected using the Stool DNA stabiliser (PSPR Spin
Stool DNA Plus Kit 00310, Invitek) and stored at 4 °C in
the hospital for a maximum of three days before process-
ing. After culture of faeces, all samples were frozen imme-
diately at −80 °C before DNA extraction.
16S rDNA pyrosequencing and data analysis
Among all the faecal samples collected, clinical history
of each subject was investigated in order to select two
homogenous groups of horses (with and without diarrhoea)
with the same number of individuals in each group. Both
groups were matched for age, pathologies, previous hospital
stay and medical treatment. A total of 20 faecal samples
(ten with diarrhoea and ten without diarrhoea) were further
studied. A second selection was done on the pool of 140
horses to gather 2 homogenous groups of horses, either or
not positive for C. difficile by classical microbiology (n = 5),
which were matched for age, pathologies, previous hospital
stay and medical treatment. Finally, the 30 samples were
grouped together in a third analysis and clustered into de-
fined diagnostic category based upon diagnostic (Table 1;
Table 2; Additional file 5). The resulting diagnostic categ-
ories are: colic—horses suffering from abdominal pain (n =
12); diarrhoea—horses with 3 or more loose or liquid stools
per day, without other symptom (n = 3); enteritis—horse
with ileon inflammation (n = 1); enterocolitis—horse with
ileon and colon inflammation (n = 1) and others—horses
with non Gastro-intestinal disorders (n = 13).
Total DNA was extracted from the stool samples with
the PSPR Spin Stool DNA Plus Kit 00310 (Invitek), fol-
lowing the manufacturer’s recommendations. The DNA
was eluted into DNase/RNase-free water and its concen-
tration and purity were evaluated by absorbance measure-
ment using the NanoDrop ND-1000 spectrophotometer
(NanoDrop ND-1000, Isogen). PCR-amplification of the
V1-V3 region of the 16S rDNA was performed as previ-
ously described [33]. Primers E9-29 and E514-530 [33–35]
were selected for their theoretical ability to generate the
lowest possible amplification capability bias among the
various bacterial phyla [36]. The oligonucleotide design
included 454 Life Sciences’ A or B sequencing titanium
adapters (Roche Diagnostics) and multiplex identifiers
(MIDs) fused to the 5′ end of each primer. The master mix
composition consisted of 5 units of FastStart high fidelity
polymerase (Roche Diagnostics), 1x enzyme reaction buffer,
200 μM dNTPs (Eurogentec), 0.2 μM of each primer and
100 ng of genomic DNA in a volume of 100 μl. The ampli-
fication was carried out in a gradient thermocycler (Eppen-
dorf) as follows: denaturation at 94 °C for 15 min followed
by 25 cycles of 94 °C for 40 s, 56 °C for 40 s; 72 °C for
1 min; and a final elongation step at 72 °C for 7 min. PCR
products were run on 1 % agarose gel electrophoresis and
purified using the SV PCR purification kit (Promega
Benelux). Picogreen dsDNA quantitation assay (Isogen)
was performed in order to assess the quality and quan-
tity of the products. All libraries were run in the same
titanium pyrosequencing reaction using Roche multiplex
identifiers, and amplicons were sequenced using the Roche
GS-Junior Genome Sequencer instrument (Roche).
Sequence reads were processed using MOTHUR soft-
ware package v1.32 [37] and denoised using the Pyro-
noise algorithm [38]. Trimming criteria of the reads was
applied as follows: read lengths no shorter than 425 bp,
an exact match to the barcode, and 1 mismatch allowed
to the proximal primer [33]. Sequences were checked for
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the presence of chimeric amplifications using the UCHIME
algorithm [39].
The read sets obtained were compared with a reference
data set of aligned sequences of the corresponding region
derived from the SILVA database (v1.15) of full-length
rDNA sequences [40] implemented in MOTHUR [41].
The final reads were clustered into operational taxonomic
units (OTUs) using the nearest MOTHUR neighbour algo-
rithm with a 0.03 distance unit cut-off. Taxonomic identity
was attributed to each OTU by comparison with the SILVA
v1.15 database [37] (80 % homogeneity cut-off) [33]. When
taxonomic identification fell below the 80 % treshold, the
taxonomic level was labelled with the first defined level
from higher level followed by the term “_unclassified”.
All unique sequences for each OTU were further com-
pared with the SILVA data set version v1.15 using the
BLASTN algorithm [42, 43], as MOTHUR is not suitable
to taxonomic assignment beyond the genus level. For each
OTU, a consensus detailed taxonomic identification was
given based upon the identity (less than 1 % of mismatch
with the aligned sequence) and the metadata associated
with the most frequent hits leading to 3 kind of label-
ling : (i) the population is identical to a taxonomically
defined species and is labelled “genus_species”; (ii) the
population is identical to a reference sequence belonging to
a still undefined species and is labelled “genus_NCBI Ac-
cession Number”; (iii) the sequence is not identical to any
known sequence and is arbitrarily labelled with its OTU
number [33].
Subsample datasets were obtained and used to evaluate
ecological indicators (the richness and microbial diversity
of the samples) using MOTHUR. Population structure and
community membership were assessed with MOTHUR
using distance matrices based on the Jaccard index (a
measure of community membership; which considers
the number of shared OTUs but not their abundance)
and the Yue and Clayton measure of dissimilarity (a meas-
ure of community structure which considers shared OTUs
and their relative abundances) [44]. Richness estimation
(Chao1 estimator) [45], microbial biodiversity (non-para-
metric (NP) Shannon diversity index) [46], and the popula-
tion evenness (Shannon evenness) [47] were calculated
using MOTHUR. Chao 1 estimator was used to esti-
mate the richness of the detected species (OTUs) in a
sample [33].
Ordination and statistical analysis and biosample accession
numbers
Ordination analysis were performed with Vegan package
in R [48].
Principal coordinate analysis (PCoA) was applied to
visualise the biodiversity between the two groups [49].
Statistical analysis regarding community structure and
composition were performed with AMOVA and UNIFRAC
implemented in MOTHUR v1.32. Analysis of molecular
variance (AMOVA) was used for estimating population dif-
ferentiation [50]. Unifrac unweighted analysis, which
accounts for the relative abundance of each of the taxa
within communities, was used to evaluate differences in
population structure between pairs of sample categories
[51]. The differences were considered significant for a
p-value of less than 0.05; all the results given are the
means ± the standard deviations of the results between
the samples of each category [33]. Statistical differences
between bacterial biodiversity, richness and evenness were
assessed using two-sided unpaired t-test using PRISM 6
(Graphpad Software). In order to highlight statistical differ-
ences in the bacterial population abundance between
categories, a White tests (paired comparisons) and ANOVA
with Tukey post-hoc test were performed using STAMP
software [52]. All the biosample sequences have been
deposited at the National Center for Biotechnology Infor-
mation (NCBI) [53] and are available under de Bioproject
ID PRJNA279335.
Clostridium difficile culture, identification and
characterisation
For isolation of C. difficile, one gram of faeces was inoc-
ulated into 9 ml of CCFT (cycloserine cefoxitin fructose
taurocholate) broth as previously described [54] and in-
cubated anaerobically for 72 h at 37 °C. A 10 μl aliquot
of the enriched broth was spread on CCFT plates and
incubated anaerobically at 37 °C for three days. One pre-
sumptive colony per plate was subcultured onto blood
agar 5 % Sheep Blood (Biorad) and checked using a C. dif-
ficile latex agglutination rapid test Kit DR 1107A (Oxoid).
Identification, toxin gene profile, deletions in the regulator
gene tcdC, and gyrA mutation (gene associated with moxi-
floxacin resistance) were determined using the Genotype
Cdiff system (Hain Lifescience) according to the manu-
facturer’s instructions. The supernatant from each pure
culture was tested for cytotoxicity assay (TcdB) using con-
fluent monolayer MRC-5 cells, as previously described
[54]. A PCR ribotyping method based on capillary gel
was performed using the primers recommended by Bidet
et al. [55]. The isolates with a PCR-ribotype profile from
which reference strains were available in our laboratory
were designated with the relevant Cardiff international
number. Otherwise, isolates were identified with an in-
ternal nomenclature beginning with UCL.
Antibiotic resistance
Clostridium difficile isolates (n = 5) were tested for sus-
ceptibilities to a panel of nine antimicrobial agents by disc
diffusion (n = 7) and E-test (n = 2). The antimicrobials
studied were chosen because they have been associ-
ated with C. difficile infection or its treatment, or
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because they were widely used in the equine teaching
hospital used in the study.
Resistance to rifampin (25 μg), erythromycin (15 μg),
oxitetracycline (30 μg), vancomycin (30 μg), penicillin
(10 μg), clindamycin (2 μg), and ceftiofur (30 μg) (Becton-
Dickinson) was tested by disc diffusion assay on Brucella
Blood Agar with hemin and vitamin K1 (Becton-
Dickinson) according to the French Society of Micro-
biology [56] protocols. Zone diameters were read
after 24 h of anaerobic incubation at 37 °C and inter-
preted as previously described [10].
Susceptibility to metronidazole and moxifloxacin was de-
termined using the Etest method (Lucron ELITechGroup)
on Schaedler with Vit K1 and 5 % sheep blood (Becton-
Dickinson) according to the manufacturer’s instructions.
Plates were incubated anaerobically at 37 °C for 48 h.
The susceptibility and resistance breakpoints for metro-
nidazole (s ≤8 μg/ml; r ≥32 μg/ml) and moxifloxacin
(s ≤ 2 μg/ml; r ≥8 μg/ml) used for interpretation were
those recommended by the Clinical and Laboratory Stand-
ard Institute [57]. Bacteroides fragilis ATCC 25285 was
tested as a quality control.
Metagenetic analysis
Rectal faecal samples of all animals positive for C. difficile
(n = 5) were analysed by 16S rDNA pyrosequencing (as de-
scribed above) in order to recover further information
about the microbiota composition of horses colonised
by the bacterium. A further group of non-colonised horses
(n = 5) was used as a control. Control subjects were se-
lected on basis of their similarity to colonised horses, in-
cluding same clinical history (pathologies and antimicrobial
treatment), age and previous hospital stay, to obtain two
groups as similar as possible.
Ethics
This study required no experimental research on animals,
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require approval from Animal Ethics Committee following
Belgian (royal decree M.B.10.07.2013) and European legisla-
tion (2010/63/UE).
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